| Patents for C07K 1 - General processes for the preparation of peptides (51,718) |
|---|
| 07/27/1999 | US5928861 Using specific antibodies against an epitope in the envelope protein gp46 for the detection of human t-cell leukemia virus in humans |
| 07/27/1999 | US5928670 Method of inhibiting aldose reductase in vivo with intrinsic inhibitors of aldose reductase |
| 07/27/1999 | US5928650 Preventing bacterial meningitis caused by serogroup b using anon-polysaccharide |
| 07/27/1999 | US5928518 Cross-flow filtration process for separating organic compound by adsorption on inorganic solids |
| 07/27/1999 | US5928484 Adding to sample or gel a cationic species or hydrophobic anionic or nonionic surfactant to alter electrophoretic mobility of lipoprotein(a) (lp(a)) relative to other native lipoproteins in sample |
| 07/27/1999 | US5928469 Process for storage of materials |
| 07/27/1999 | CA1340684C Antiherpes pentapeptides |
| 07/27/1999 | CA1340682C Antiviral peptides having a 2-oxoalkyl amino acid side chain |
| 07/22/1999 | WO1999036568A2 Method for identifying t-cell stimulating protein fragments |
| 07/22/1999 | WO1999036552A1 Method for producing purified and optionally marked tsh receptor preparations, radioiodized tsh receptor preparations and the use of preparations of this type in diagnostics and therapy |
| 07/22/1999 | WO1999036430A1 Oligoligands with a binding capacity |
| 07/22/1999 | WO1999036088A1 RECOMBINANT CtB-BASED VACCINES |
| 07/21/1999 | EP0929680A1 Thermostable dna polymerase from carboxydothermus hydrogenoformans |
| 07/21/1999 | EP0929679A2 Histidine-tagged shiga toxins, toxoids, and protein fusions with such toxins and toxoids, methods for the purification and preparation thereof |
| 07/21/1999 | EP0929570A1 Modified cytostatic agents |
| 07/21/1999 | EP0929567A1 Improved solid-phase peptide synthesis and agent for use in such synthesis |
| 07/21/1999 | CN1223690A Antiangiogenic peptides derived from plasminogen, its coded polynucleotide and method of inhibiting vascularization |
| 07/21/1999 | CN1223664A Serine protease inhibitors |
| 07/20/1999 | US5925737 Whey protein fractionation using high pressure or supercritical carbon dioxide |
| 07/20/1999 | US5925732 Chemical reaction apparatus for performing multiple reaction on a surface and collecting the product |
| 07/20/1999 | US5925562 Remotely programmable matrices with memories |
| 07/20/1999 | US5925525 Method of identifying nucleotide differences |
| 07/20/1999 | US5925331 Technetium-99m labeled peptides for thrombus imaging |
| 07/20/1999 | CA2146367C Calcium channel blocking polypeptides from heteropoda venatoria |
| 07/20/1999 | CA2069043C Quantitation of samples utilizing capillary electrophoresis |
| 07/20/1999 | CA1340667C Peptides having bradykinin antagonist action |
| 07/20/1999 | CA1340656C Membrane anchor/active compound conjugate, its preparation and its use |
| 07/15/1999 | WO1999035598A1 Method for providing, identifying and describing molecules capable of having a required activity, in particular in pharmacology and molecules resulting from said method |
| 07/15/1999 | WO1999035248A2 Method of refolding angiostatin |
| 07/15/1999 | WO1999019363B1 Monoclonal antibody to alpha2-macroglobulin and its use for detecting glucan |
| 07/15/1999 | WO1998055501A9 Improved method for site-selective glycosylation |
| 07/15/1999 | DE19801154A1 Preparation of pure recombinant thyroid stimulating hormone receptor useful for detection of autoantibodies in human serum |
| 07/15/1999 | DE19800899A1 Preparation of oligo-ligands for macromolecules with optionally unknown composition of building blocks |
| 07/15/1999 | CA2315364A1 Method for providing, identifying and describing molecules capable of having a required activity, in particular in pharmacology and molecules resulting from said method |
| 07/14/1999 | EP0928336A1 Chaperone fragments |
| 07/14/1999 | EP0928295A1 Purification of immunoglobulins |
| 07/14/1999 | EP0928294A1 Method and apparatus for preparing an acellular red blood cell substitute |
| 07/14/1999 | EP0574414B1 LIGAND GROWTH FACTORS THAT BIND TO THE erbB-2 RECEPTOR PROTEIN AND INDUCE CELLULAR RESPONSES |
| 07/14/1999 | CN1222917A Novel protein and process for producing the same |
| 07/14/1999 | CN1222526A Preparation of epidermal growth factor with marine products and relevant discard |
| 07/14/1999 | CN1044121C Method for isolating coagulation factors VIII complex |
| 07/14/1999 | CN1044120C Method for depolymerizing inclusion body with power ultra sound |
| 07/13/1999 | US5922890 Trityl amide or acid linkers for solid phase synthesis |
| 07/13/1999 | US5922858 Misaminoacylated transfer ribonucleic acid with photocleavable marker; for incorporation of non-radioactive labels into nascent proteins by cellular or cell-free translation systems |
| 07/13/1999 | US5922848 Purifying toxin from sample by forming complex with galactose disaccharide covalently bonded through linker arm to support, separating complex from sample, recovering eluted toxin under alkaline, non-denaturing conditions; free of glycolipids |
| 07/13/1999 | US5922846 Process for refolding recombinantly produced TGF-β-like proteins |
| 07/13/1999 | US5922840 Methods for purifying synthetic peptides |
| 07/13/1999 | US5922567 Two new human DNAJ-like proteins |
| 07/13/1999 | US5922548 Anti α-gal screening technique |
| 07/13/1999 | US5922541 Method for detection of PF4A receptor nucleic acid |
| 07/13/1999 | US5922322 Cleaves at the gamma glycine404-alanine405 peptide bond; apply to medical equipment to inhibit thrombus formation; administering to treat restenosis post-surgery, to inhibit vascular reocclusion |
| 07/13/1999 | US5922303 Technetium-99M labeled peptides for imaging |
| 07/13/1999 | CA2121257C Stabilised antibodies |
| 07/13/1999 | CA1340650C Artificial gene coding for authentic human serum albumin, use thereof, and method of producing the same |
| 07/13/1999 | CA1340649C Purified follicle stimulating hormone |
| 07/13/1999 | CA1340646C Cyclic anticoagulant peptides |
| 07/13/1999 | CA1340641C Recombinant lymphotoxin |
| 07/08/1999 | WO1999033988A1 A process for preparing human proinsulin |
| 07/08/1999 | WO1999033969A1 A method of isolating a peptide which immunologically mimics microbial carbohydrates including group b streptococcal carbohydrates and the use thereof in a vaccine |
| 07/08/1999 | WO1999033862A1 Free solution ligand interaction molecular separation method |
| 07/08/1999 | WO1999033860A1 Method for binding albumin and means to be used in the method |
| 07/08/1999 | WO1999033768A1 Materials for screening of combinatorial libraries |
| 07/08/1999 | WO1999023109A3 A method for mapping the active sites bound by enzymes that covalently modify substrate molecules |
| 07/08/1999 | CA2317029A1 A method of isolating a peptide which immunologically mimics microbial carbohydrates including group b streptococcal carbohydrates and the use thereof in a vaccine |
| 07/08/1999 | CA2316766A1 Method for binding albumin and means to be used in the method |
| 07/08/1999 | CA2315750A1 A process for preparing human proinsulin |
| 07/07/1999 | EP0759029B1 Modified milk growth factor |
| 07/07/1999 | EP0570381B1 Method for immobilization of thiol compounds via activation of polymers, activated polymers, and products obtained by the method |
| 07/07/1999 | CN1222193A Extracellular matrix signalling molecules |
| 07/07/1999 | CN1221751A Extract of mammal eyes |
| 07/07/1999 | CN1043998C Process for simultaneous renaturation and purification of denatured protein |
| 07/06/1999 | US5919913 Isolation of lactoferrin from milk |
| 07/06/1999 | US5919909 Precipitating proteins using ammonium sulfate at concentration of 1.5 to 2.3 mol/liter then affinity chromatography separation |
| 07/06/1999 | US5919709 Control peptides designed for use in monitoring the proper operation of amino acid sequencers; obtain data for amino acids within 15 seqencer cycles and to provide cleavage sites for 4 different amino acid cleavage reactions |
| 07/06/1999 | US5919637 Method for identifying reduced binding between GMP-140 and GMP-140 ligand |
| 07/06/1999 | US5919616 Serological assay for herpes |
| 07/06/1999 | US5919615 Polypeptides and antibodies characteristic of papillomavirus, and diagnostic procedures and vaccines making use of them |
| 07/06/1999 | CA2098397C Physiologically active substance designated as epimorphin, genes encoding the same, and antibodies thereto |
| 07/06/1999 | CA2000604C Process for the activation of genetechnologically produced, biologically-active proteins expressed in prokaryotes |
| 07/01/1999 | WO1999032595A1 Granule with hydrated barrier material |
| 07/01/1999 | WO1999032520A1 Method for quantitating denatured ldls |
| 07/01/1999 | WO1999032508A1 Process for the preparation of solid polymer composites |
| 07/01/1999 | WO1999032428A2 Synthesis of diamines |
| 07/01/1999 | WO1999032142A1 Beta-lipotropin and uses thereof |
| 07/01/1999 | WO1999032140A1 Alpha-interferon-polymer-conjugates having enhanced biological activity and methods of preparing the same |
| 07/01/1999 | WO1999032134A1 Substantially pure histidine-linked protein polymer conjugates |
| 07/01/1999 | WO1999012962A8 Inhibitors of phosphoserine and phosphothreonine-proline-specific isomerases |
| 07/01/1999 | CA2315888A1 Beta-lipotropin and uses thereof |
| 07/01/1999 | CA2315280A1 Method for quantifying denatured ldl |
| 06/30/1999 | EP0926239A2 Beta-lipotropin and uses thereof |
| 06/30/1999 | EP0926158A1 Crystalline parathyroid hormone |
| 06/30/1999 | EP0925502A1 Diagnostic and therapeutic nucleotide or nucleoside photoaffinity compound modified antibodies, and use thereof |
| 06/30/1999 | EP0925110A1 Conjugate useful for binding substances |
| 06/30/1999 | EP0748337B1 Process for the obtention of a biological adhesive comprising fibrinogen, factor xiii and fibronectin |
| 06/30/1999 | EP0470128B1 Active carbonates of polyalkylene oxides for modification of polypeptides |
| 06/30/1999 | CN1221425A Method for chromatographic removal of prions |
| 06/30/1999 | CN1221424A 肽衍生物 Peptide derivatives |
| 06/29/1999 | US5917022 From a biological produc by contacting said biological product with cross-linked hydrophilic matrix comprising a copolymer of allyl dextran and n,n'-methylene bisacrylamide |
| 06/29/1999 | US5917018 Method for producing correctly folded proteins from a mixture of misfolded proteins, e.g. bacterial inclusion-body aggregates |
| 06/29/1999 | US5917016 Useful as photocleavable linking groups in solid phase synthesis |